The company filed for bankruptcy protection on April 24, 2024 with significant liabilities. The company was founded in 2010 and previously operated as a publicly-traded entity on the Canadian Securities Exchange before its financial decline.
Cyborg Score Rationale
MedMen filed for bankruptcy in April 2024 after years of operational and financial challenges. The company's stock became inactive by April 2026. Structural distress in the cannabis retail sector, combined with company-specific management and financial issues, has rendered the business severely challenged.
Top Insights
Filed for bankruptcy protection (April 2024) with approximately $411 million USD in liabilities
Stock trading became inactive by April 2026 on OTC markets
Legacy brand recognition in cannabis retail but operational viability severely compromised
Multiple leadership changes in 2023-2024 preceding bankruptcy filing
Named Competitors
Trulieve — Major U.S. cannabis retailer
Curaleaf — Multi-state cannabis operator
Cresco Labs — Vertically integrated cannabis company
Recent Developments
(January 2024) CEO Ellen Deutsch Harrison stepped down; Richard Ormond appointed as Chief Restructuring Officer
(April 2024) Company filed for bankruptcy under Canada's Bankruptcy and Insolvency Act
(April 2026) Stock trading marked as inactive on OTC markets
Open the full interactive MedMen Enterprises, Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.